Company Analysis Kobayashi Pharmaceutical Co., Ltd.
1. Summary
Advantages
- Current debt level 0.369% is below 100% and has decreased over 5 years from 0.3817%.
- The company's current efficiency (ROE=9.93%) is higher than the sector average (ROE=6.91%)
Disadvantages
- Price (5604 Β₯) is higher than fair price (3155.42 Β₯)
- Dividends (2.64%) are below the sector average (4.02%).
- The stock's return over the last year (-7.13%) is lower than the sector average (0.079%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Kobayashi Pharmaceutical Co., Ltd. | Index | ||
|---|---|---|---|
| 7 days | -1.4% | -0% | -4.2% |
| 90 days | -7.4% | 14.1% | -3.5% |
| 1 year | -7.1% | 0.1% | -5.2% |
4967 vs Sector: Kobayashi Pharmaceutical Co., Ltd. has significantly underperformed the "" sector by -7.21% over the past year.
4967 vs Market: Kobayashi Pharmaceutical Co., Ltd. has underperformed the market marginally by -1.9% over the past year.
Stable price: 4967 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4967 with weekly volatility of -0.1372% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (5604 Β₯) is higher than the fair price (3155.42 Β₯).
Price is higher than fair: The current price (5604 Β₯) is 43.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (24.98) is lower than that of the sector as a whole (118.28).
P/E vs Market: The company's P/E (24.98) is lower than that of the market as a whole (125.3).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.48) is lower than that of the sector as a whole (99.03).
P/BV vs Market: The company's P/BV (2.48) is lower than that of the market as a whole (92.28).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.93) is lower than that of the sector as a whole (98.9).
P/S vs Market: The company's P/S indicator (2.93) is lower than that of the market as a whole (92.26).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (13.74) is lower than that of the sector as a whole (125.67).
EV/Ebitda vs Market: The company's EV/Ebitda (13.74) is lower than that of the market as a whole (98.71).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 1.17% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (1.17%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-11.19%).
5.4. ROE
ROE vs Sector: The company's ROE (9.93%) is higher than that of the sector as a whole (6.91%).
ROE vs Market: The company's ROE (9.93%) is higher than that of the market as a whole (7.67%).
5.5. ROA
ROA vs Sector: The company's ROA (7.6%) is higher than that of the sector as a whole (3.68%).
ROA vs Market: The company's ROA (7.6%) is higher than that of the market as a whole (3.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (6.77%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.77%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 2.64% is below the average for the sector '4.02%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.64% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 2.64% has been growing over the last 5 years. Growth over 6 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (35.51%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
